Skip to content

Effect of Unani formulation in Acne Vulgaris

Efficacy of Nuqoo-e-Sarphuka and Tila (Maghz-e-tukhm-e-beri, Mulethi, Qust Talkh) in Busoore Labaniya (Acne Vulgaris).

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044595
Enrollment
30
Registered
2022-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Efficacy of nuqoo e sarphuka and Tila of maghz e tukhm e beri mulethi and qust talkh: 7grams of sarphuka soaked overnight given in morning on empty stomach for 21 days and for local app

Sponsors

Government Unani Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group 15 to 35years Both the genders Clinically diagnosed patients of Acne vulgaris Patients with a score of 1 to 30 that is mild to moderate according to GAGS Patients or Guardians who agree to sign the informed consent form and follow the protocol

Exclusion criteria

Exclusion criteria: Age less than 15 and more than 35 years Patients having local wound and infection on face Pregnant and lactating women Mentally retarded Patients with systemic diseases like Tuberculosis Bronchial Asthma DM HTN and CKD Patients on corticosteroid therapy anticonvulsant therapy using retinoid or taking OCP Patients who do not cooperate and fail follow up Patients whose GAGS was assessed to be severe and very severe a score which is more than or equal to 31

Design outcomes

Primary

MeasureTime frame
Reduction of acne in photographs Improvement in GAG score Improvement in Cardiff acne disability index Timepoint: 0th,7th,14th 21st day

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Umai Sumaiya Banu

Rajiv Gandhi University of Health Sciences Bangalore

ayesharafeeq81@yahoo.com9035158024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026